Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Multiple Sclerosis

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    December 2024
  1. LANZ TV, Robinson WH
    Connecting the dots: Presentation of EBV antigens on HLA class II risk alleles connects the two main risk factors of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2024;121:e2420070121.
    PubMed    


    November 2024
  2. OKAMOTO M, Kuratani A, Okuzaki D, Kamiyama N, et al
    IFN-gamma-induced Th1-Treg polarization in inflamed brains limits exacerbation of experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2024;121:e2401692121.
    PubMed     Abstract available


    October 2024

  3. Correction for Poon et al., Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2024;121:e2420080121.
    PubMed    


  4. DROSU N, Anderson M, Bilodeau PA, Nishiyama S, et al
    CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation.
    Proc Natl Acad Sci U S A. 2024;121:e2416097121.
    PubMed     Abstract available


    August 2024
  5. DENEEN B
    Pipe dream: Remyelination therapy for multiple sclerosis.
    Proc Natl Acad Sci U S A. 2024;121:e2414324121.
    PubMed    


  6. ALAKHRAS NS, Zhang W, Barros N, Sharma A, et al
    An IL-23-STAT4 pathway is required for the proinflammatory function of classical dendritic cells during CNS inflammation.
    Proc Natl Acad Sci U S A. 2024;121:e2400153121.
    PubMed     Abstract available


  7. POON MM, Lorrain KI, Stebbins KJ, Edu GC, et al
    Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2024;121:e2407974121.
    PubMed     Abstract available


    July 2024
  8. NATARAJAN C, Le LHD, Gunasekaran M, Tracey KJ, et al
    Electrical stimulation of the vagus nerve ameliorates inflammation and disease activity in a rat EAE model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2024;121:e2322577121.
    PubMed     Abstract available


    June 2024
  9. RAKEBRANDT N, Yassini N, Kolz A, Schorer M, et al
    Innate acting memory Th1 cells modulate heterologous diseases.
    Proc Natl Acad Sci U S A. 2024;121:e2312837121.
    PubMed     Abstract available


    February 2024
  10. ADAMS C, Manouchehrinia A, Quach HL, Quach DL, et al
    Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans.
    Proc Natl Acad Sci U S A. 2024;121:e2302259121.
    PubMed     Abstract available


    January 2024
  11. SUTTER PA, Willis CM, Menoret A, Nicaise AM, et al
    Astrocytic TIMP-1 regulates production of Anastellin, an inhibitor of oligodendrocyte differentiation and FTY720 responses.
    Proc Natl Acad Sci U S A. 2024;121:e2306816121.
    PubMed     Abstract available


  12. GOTTLIEB A, Pham HPT, Saltarrelli JG, Lindsey JW, et al
    Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells.
    Proc Natl Acad Sci U S A. 2024;121:e2315857121.
    PubMed     Abstract available


    November 2023
  13. THOMANN AS, McQuade CA, Pinjusic K, Kolz A, et al
    A B cell-driven EAE mouse model reveals the impact of B cell-derived cytokines on CNS autoimmunity.
    Proc Natl Acad Sci U S A. 2023;120:e2300733120.
    PubMed     Abstract available


    September 2023
  14. GRUCHOT J, Lewen I, Dietrich M, Reiche L, et al
    Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment.
    Proc Natl Acad Sci U S A. 2023;120:e2308187120.
    PubMed     Abstract available


  15. GARCIA CORRALES AV, Verberk SGS, Haidar M, Grajchen E, et al
    Fatty acid elongation by ELOVL6 hampers remyelination by promoting inflammatory foam cell formation during demyelination.
    Proc Natl Acad Sci U S A. 2023;120:e2301030120.
    PubMed     Abstract available


    May 2023
  16. CAVERZASI E, Papinutto N, Cordano C, Kirkish G, et al
    MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.
    Proc Natl Acad Sci U S A. 2023;120:e2217635120.
    PubMed     Abstract available


    April 2023
  17. KAPATE N, Dunne M, Kumbhojkar N, Prakash S, et al
    A backpack-based myeloid cell therapy for multiple sclerosis.
    Proc Natl Acad Sci U S A. 2023;120:e2221535120.
    PubMed     Abstract available


  18. GHAREGHANI M, Zibara K, Rivest S
    Melatonin and vitamin D, two sides of the same coin, better to land on its edge to improve multiple sclerosis.
    Proc Natl Acad Sci U S A. 2023;120:e2219334120.
    PubMed     Abstract available


    March 2023
  19. MADER S, Ho S, Wong HK, Baier S, et al
    Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein.
    Proc Natl Acad Sci U S A. 2023;120:e2300648120.
    PubMed     Abstract available


    February 2023
  20. HEMING M, Wiendl H
    Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy.
    Proc Natl Acad Sci U S A. 2023;120:e2221544120.
    PubMed    


    January 2023
  21. SHINODA K, Li R, Rezk A, Mexhitaj I, et al
    Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
    Proc Natl Acad Sci U S A. 2023;120:e2207291120.
    PubMed     Abstract available


  22. JANOSCHKA C, Lindner M, Koppers N, Starost L, et al
    Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
    Proc Natl Acad Sci U S A. 2023;120:e2209944120.
    PubMed     Abstract available


    October 2022
  23. KWIATKOWSKI AJ, Helm EY, Stewart JM, Drashansky TT, et al
    Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in mice.
    Proc Natl Acad Sci U S A. 2022;119:e2205417119.
    PubMed     Abstract available


  24. BEHRANGI N, Heinig L, Frintrop L, Santrau E, et al
    Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.
    Proc Natl Acad Sci U S A. 2022;119:e2204509119.
    PubMed     Abstract available


    August 2022
  25. MEYER T, Shimon D, Youssef S, Yankovitz G, et al
    NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.
    Proc Natl Acad Sci U S A. 2022;119:e2211310119.
    PubMed     Abstract available


  26. DIEBOLD M, Galli E, Kopf A, Sanderson NSR, et al
    High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2022;119:e2205042119.
    PubMed     Abstract available


    June 2022
  27. ZAHOOR I, Suhail H, Datta I, Ahmed ME, et al
    Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.
    Proc Natl Acad Sci U S A. 2022;119:e2123265119.
    PubMed     Abstract available


  28. KIM S, Lu HC, Steelman AJ, Li J, et al
    Myeloid caspase-8 restricts RIPK3-dependent proinflammatory IL-1beta production and CD4 T cell activation in autoimmune demyelination.
    Proc Natl Acad Sci U S A. 2022;119:e2117636119.
    PubMed     Abstract available


    April 2022
  29. YU L, He L, Gan B, Ti R, et al
    Structural insights into sphingosine-1-phosphate receptor activation.
    Proc Natl Acad Sci U S A. 2022;119:e2117716119.
    PubMed     Abstract available


  30. HWANG D, Seyedsadr MS, Ishikawa LLW, Boehm A, et al
    CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
    Proc Natl Acad Sci U S A. 2022;119:e2111804119.
    PubMed     Abstract available


    March 2022
  31. SARRAZIN N, Chavret-Reculon E, Bachelin C, Felfli M, et al
    Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction.
    Proc Natl Acad Sci U S A. 2022;119:e2115973119.
    PubMed     Abstract available


  32. CHUNDER R, Weier A, Maurer H, Luber N, et al
    Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination.
    Proc Natl Acad Sci U S A. 2022;119:e2117034119.
    PubMed     Abstract available


    February 2022
  33. GUO X, Kimura A, Namekata K, Harada C, et al
    ASK1 signaling regulates phase-specific glial interactions during neuroinflammation.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available


    December 2021
  34. MA Q, Caillier SJ, Muzic S, Wilson MR, et al
    Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  35. CHANDRAN V, Bermudez ML, Koka M, Chandran B, et al
    Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    November 2021
  36. VARATHARAJ A, Carare RO, Weller RO, Gawne-Cain M, et al
    Gadolinium enhancement of cranial nerves: Implications for interstitial fluid drainage from brainstem into cranial nerves in humans.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    October 2021
  37. MANOUCHEHRI N, Stuve O
    Choroid plexus volumetrics and brain inflammation in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    September 2021
  38. FLEISCHER V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, et al
    Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  39. HARTLEHNERT M, Borsch AL, Li X, Burmeister M, et al
    Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    August 2021
  40. LONGBRAKE EE, Hafler DA
    (23)Na imaging: Worth its salt for understanding multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  41. JING X, Yao Y, Wu D, Hong H, et al
    IFP35 family proteins promote neuroinflammation and multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    July 2021

  42. Correction for Ostkamp et al., Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  43. HUHN K, Linz P, Pemsel F, Michalke B, et al
    Skin sodium is increased in male patients with multiple sclerosis and related animal models.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  44. COLOMBO E, Triolo D, Bassani C, Bedogni F, et al
    Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  45. PATERGNANI S, Bonora M, Ingusci S, Previati M, et al
    Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  46. BARNES SE, Han MH
    CD317 puts the brakes on dendritic cell trafficking to the CNS.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    April 2021
  47. ZHELEZNYAKOVA GY, Piket E, Needhamsen M, Hagemann-Jensen M, et al
    Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  48. RONIN E, Pouchy C, Khosravi M, Hilaire M, et al
    Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells.
    Proc Natl Acad Sci U S A. 2021;118:e2014043118.
    PubMed     Abstract available


  49. RAVENEY BJE, Sato W, Takewaki D, Zhang C, et al
    Involvement of cytotoxic Eomes-expressing CD4(+) T cells in secondary progressive multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  50. KHAW YM, Tierney A, Cunningham C, Soto-Diaz K, et al
    Astrocytes lure CXCR2-expressing CD4(+) T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  51. TEO W, Caprariello AV, Morgan ML, Luchicchi A, et al
    Nile Red fluorescence spectroscopy reports early physicochemical changes in myelin with high sensitivity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  52. OSTKAMP P, Salmen A, Pignolet B, Gorlich D, et al
    Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  53. KENISON JE, Jhaveri A, Li Z, Khadse N, et al
    Tolerogenic nanoparticles suppress central nervous system inflammation.
    Proc Natl Acad Sci U S A. 2020;117:32017-32028.
    PubMed     Abstract available


    October 2020
  54. MONTGOMERY TL, Kunstner A, Kennedy JJ, Fang Q, et al
    Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
    Proc Natl Acad Sci U S A. 2020 Oct 19. pii: 2002817117.
    PubMed     Abstract available


    September 2020
  55. NISSIMOV N, Hajiyeva Z, Torke S, Grondey K, et al
    B cells reappear less mature and more activated after their anti-CD20-mediated depletion in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2020 Sep 30. pii: 2012249117.
    PubMed     Abstract available


  56. DIDONNA A, Canto Puig E, Ma Q, Matsunaga A, et al
    Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.
    Proc Natl Acad Sci U S A. 2020 Sep 2. pii: 2003798117.
    PubMed     Abstract available


  57. MONDAL S, Kundu M, Jana M, Roy A, et al
    IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rbeta1 internalization and suppress EAE.
    Proc Natl Acad Sci U S A. 2020;117:21557-21567.
    PubMed     Abstract available


    August 2020
  58. O'CONNELL GC, Alder ML, Smothers CG, Chang JHC, et al
    Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage.
    Proc Natl Acad Sci U S A. 2020;117:20764-20775.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.